Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content

Women in STEM: Inspiration from Innovators in Pharma

BySusan Haigney

February 2nd 2026

Cellares Secures $257M | Created with Canva

Cellares Secures $257M to Scale Global Cell Therapy Manufacturing

ByChristopher Cole

January 29th 2026

Nerve cell with blue background attacked by red antibodies - 3D illustration of autoimmune disease | Image Source: ©peterschreiber.media -stock.adobe.com

Repertoire Immune Medicines and Lilly Collaborate on Treatments for Autoimmune Diseases

BySusan Haigney

January 29th 2026

Leveraging Next-Gen Therapies, Advanced Purification, and Strategic Collaborations in Pharma Production

BySusan Haigney,Zachary Zubulake

January 26th 2026

Integrating AI Discovery, Continuous Manufacturing, and Modern Regulatory Hurdles into Pharma Production

BySusan Haigney

January 23rd 2026

Outsourcing Outlook

Articles in this issue

Newsletter

Related Content

Women in STEM: Inspiration from Innovators in Pharma

Cellares Secures $257M to Scale Global Cell Therapy Manufacturing

Repertoire Immune Medicines and Lilly Collaborate on Treatments for Autoimmune Diseases

Leveraging Next-Gen Therapies, Advanced Purification, and Strategic Collaborations in Pharma Production

Integrating AI Discovery, Continuous Manufacturing, and Modern Regulatory Hurdles into Pharma Production

Trending on Pharmaceutical Technology

Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up

Women in STEM: Early Phase Drug Development

Rare Disease Treatments: Navigating the Economics of Global Innovation

FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B

PharmTech Weekly Roundup - February 6, 2026